Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with
potential to provide greater clinical benefit to patients with advanced-stage cancer. In …
potential to provide greater clinical benefit to patients with advanced-stage cancer. In …
Tumor heterogeneity: a great barrier in the age of cancer immunotherapy
Simple Summary Despite great advances in cancer therapy, tumor heterogeneity continues
to be a great barrier for the successful treatment of cancer. It has long been established that …
to be a great barrier for the successful treatment of cancer. It has long been established that …
A candidate multi-epitope vaccine against SARS-CoV-2
In the past two decades, 7 coronaviruses have infected the human population, with two
major outbreaks caused by SARS-CoV and MERS-CoV in the year 2002 and 2012 …
major outbreaks caused by SARS-CoV and MERS-CoV in the year 2002 and 2012 …
Contriving multi-epitope subunit of vaccine for COVID-19: immunoinformatics approaches
R Dong, Z Chu, F Yu, Y Zha - Frontiers in immunology, 2020 - frontiersin.org
COVID-19 has recently become the most serious threat to public health, and its prevalence
has been increasing at an alarming rate. The incubation period for the virus is~ 1–14 days …
has been increasing at an alarming rate. The incubation period for the virus is~ 1–14 days …
Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection
Dengue is considered as a major health issue which causes a number of deaths worldwide
each year; tropical countries are majorly affected by dengue outbreaks. It is considered as …
each year; tropical countries are majorly affected by dengue outbreaks. It is considered as …
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants
W Tai, S Feng, B Chai, S Lu, G Zhao, D Chen… - Nature …, 2023 - nature.com
Herd immunity achieved through mass vaccination is an effective approach to prevent
contagious diseases. Nonetheless, emerging SARS-CoV-2 variants with frequent mutations …
contagious diseases. Nonetheless, emerging SARS-CoV-2 variants with frequent mutations …
Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target
RCO Sanches, S Tiwari, LCG Ferreira… - Frontiers in …, 2021 - frontiersin.org
Schistosomiasis remains a serious health issue nowadays for an estimated one billion
people in 79 countries around the world. Great efforts have been made to identify good …
people in 79 countries around the world. Great efforts have been made to identify good …
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches
SARS-CoV-2 causes a severe respiratory disease called COVID-19. Currently, global health
is facing its devastating outbreak. However, there is no vaccine available against this virus …
is facing its devastating outbreak. However, there is no vaccine available against this virus …
Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein
Malaria fever has been pervasive for quite a while in tropical develo** regions causing
high morbidity and mortality. The causal organism is a protozoan parasite of genus …
high morbidity and mortality. The causal organism is a protozoan parasite of genus …
Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus
Staphylococcus aureus is a pathogen that causes a variety of infections in humans.
Methicillin-resistant S. aureus, which is an antibiotic-resistant form, is responsible for …
Methicillin-resistant S. aureus, which is an antibiotic-resistant form, is responsible for …